S Sone Selected Research

S Sone Research Topics

Disease

16	Neoplasms (Cancer) 11/2001 - 01/2000
15	Lung Neoplasms (Lung Cancer) 09/2013 - 01/2000
6	Inflammation (Inflammations) 03/2012 - 02/2001
5	Asthma (Bronchial Asthma) 03/2012 - 01/2003
5	Neoplasm Metastasis (Metastasis) 07/2001 - 01/2000
3	Rheumatoid Arthritis 03/2008 - 12/2000
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2001 - 01/2000
2	Infections 01/2018 - 08/2000
2	Fibrosis (Cirrhosis) 03/2012 - 01/2011
2	Sarcoidosis (Schaumann Disease) 08/2011 - 05/2000
2	Pulmonary Sarcoidosis 08/2007 - 05/2000
1	Hepatitis C 01/2018
1	Respiratory Hypersensitivity 03/2012
1	Necrosis 08/2011
1	Granuloma 08/2011
1	Hyperplasia 01/2011
1	Airway Remodeling 01/2011
1	Hypertrophy 01/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2001
1	Hypersensitivity (Allergy) 08/2001
1	Idiopathic Pulmonary Fibrosis 08/2001
1	Pneumonia (Pneumonitis) 07/2001
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2001
1	Radiation Pneumonitis 07/2001
1	Malignant Pleural Effusion 01/2001
1	Glioma (Gliomas) 01/2001
1	Adenocarcinoma of Lung 12/2000
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2000

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 08/2011 - 01/2000
5	AntigensIBA 03/2012 - 01/2000
4	Proteins (Proteins, Gene)FDA Link 09/2013 - 05/2000
4	ChemokinesIBA 08/2011 - 02/2000
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008 - 01/2000
3	Monoclonal AntibodiesIBA 11/2001 - 01/2000
3	InterleukinsIBA 11/2001 - 02/2000
3	Interleukin-1alpha (Interleukin 1 alpha)IBA 08/2001 - 01/2000
3	G(M2) Ganglioside (Ganglioside GM2)IBA 04/2001 - 01/2000
3	GadoliniumIBA 01/2001 - 07/2000
2	Phosphotransferases (Kinase)IBA 09/2013 - 01/2011
2	Complementary DNA (cDNA)IBA 08/2011 - 10/2001
2	InterferonsIBA 08/2011 - 08/2007
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2004 - 01/2003
2	Interleukin-12 (IL 12)IBA 07/2003 - 01/2000
2	Therapeutic UsesIBA 01/2003 - 07/2001
2	AutoantibodiesIBA 08/2001 - 12/2000
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2001 - 01/2000
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 09/2013
1	ErbB Receptors (EGF Receptor)IBA 09/2013
1	3-Phosphoinositide-Dependent Protein KinasesIBA 09/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2013
1	Nerve Growth Factors (Neurotrophins)IBA 03/2012
1	Substance PIBA 03/2012
1	Nerve Growth Factor (NGF)IBA 03/2012
1	Small Interfering RNA (siRNA)IBA 03/2012
1	Transcription Factors (Transcription Factor)IBA 01/2011
1	CollagenIBA 01/2011
1	AllergensIBA 01/2011
1	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 01/2011
1	Biomarkers (Surrogate Marker)IBA 03/2008
1	Blood Proteins (Serum Proteins)IBA 03/2008
1	EnzymesIBA 08/2007
1	LigandsIBA 08/2007
1	CXCR3 ReceptorsIBA 08/2007
1	ImmunosorbentsIBA 08/2007
1	pranlukastIBA 01/2004
1	cysteinyl-leukotrieneIBA 01/2004
1	suplatast tosilateIBA 01/2003
1	Immunoglobulin E (IgE)IBA 01/2003
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2001
1	Pain-FreeIBA 11/2001
1	Peptide Hydrolases (Proteases)FDA Link 08/2001
1	Chymases (Chymase)IBA 08/2001
1	Serine Proteases (Serine Protease)IBA 08/2001
1	quinolineIBA 07/2001
1	Etoposide (VP 16)FDA LinkGeneric 07/2001
1	dofequidar (MS 209)IBA 07/2001
1	Thrombin FDA Link 07/2001
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2001
1	Platinum Compounds (Compounds, Platinum)IBA 05/2001
1	GangliosidesIBA 04/2001
1	Matrix Metalloproteinase InhibitorsIBA 04/2001
1	ChloridesIBA 02/2001
1	Erythromycin (Erycette)FDA LinkGeneric 02/2001
1	Interleukin-15 (Interleukin 15)IBA 01/2001
1	Interleukin-2 (IL2)IBA 01/2001
1	NF-kappa B (NF-kB)IBA 01/2001
1	Decitabine FDA Link 01/2001
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2000
1	Immunoglobulin G (IgG)IBA 12/2000
1	Rheumatoid FactorIBA 12/2000
1	C-Reactive ProteinIBA 12/2000
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2000

Therapy/Procedure

8	Therapeutics 03/2008 - 02/2000
4	Immunotherapy 11/2001 - 01/2000
2	Drug Therapy (Chemotherapy) 07/2001 - 05/2000
2	Intravenous Injections 07/2001 - 01/2000
1	Biological Therapy 04/2001
1	Pneumonectomy (Lung Volume Reduction) 03/2001
1	Molecular Targeted Therapy 02/2001